Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


11.02.2019

1 Ann Neurol
1 Biochemistry
1 Biol Psychiatry
2 BMC Neurol
2 J Neural Transm (Vienna)
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
3 Mov Disord
1 Neurobiol Dis
1 Neurochem Res
1 Neurosci Lett
1 Neuroscience


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. BOHNEN NI, Kanel P, Zhou Z, Koeppe RA, et al
    Cholinergic system changes of falls and freezing of gait in Parkinson disease.
    Ann Neurol. 2019 Feb 5. doi: 10.1002/ana.25430.
    PubMed     Text format     Abstract available


    Biochemistry

  2. JAIN MK, Singh P, Roy S, Bhat R, et al
    Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human alpha-, beta-, and gamma-Synuclein Proteins.
    Biochemistry. 2018;57:3830-3848.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  3. SU Y, Deng MF, Xiong W, Xie AJ, et al
    MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson's Disease.
    Biol Psychiatry. 2018 Dec 19. pii: S0006-3223(18)32086.
    PubMed     Text format     Abstract available


    BMC Neurol

  4. WANG XY, Han YY, Li G, Zhang B, et al
    Association between autonomic dysfunction and olfactory dysfunction in Parkinson's disease in southern Chinese.
    BMC Neurol. 2019;19:17.
    PubMed     Text format     Abstract available

  5. ZHANG P, Li Y, Nie K, Wang L, et al
    Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review.
    BMC Neurol. 2018;18:221.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  6. EBERSBACH G, Ip CW, Klebe S, Koschel J, et al
    Management of delirium in Parkinson's disease.
    J Neural Transm (Vienna). 2019 Feb 6. pii: 10.1007/s00702-019-01980.
    PubMed     Text format     Abstract available

  7. DELLAPINA E, Pellaprat J, Adel D, Llido J, et al
    Dopaminergic denervation using [(123)I]-FPCIT and pain in Parkinson's disease: a correlation study.
    J Neural Transm (Vienna). 2019 Jan 31. pii: 10.1007/s00702-019-01974.
    PubMed     Text format     Abstract available


    J Neurochem

  8. BILLINGS JL, Gordon SL, Rawling T, Doble PA, et al
    L-DOPA modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    J Neurochem. 2019 Feb 4. doi: 10.1111/jnc.14676.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  9. BARBOSA PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, et al
    The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Feb 1. pii: jnnp-2018-319891.
    PubMed     Text format    


    Mov Disord

  10. SCHRAG A, Anastasiou Z, Ambler G, Noyce A, et al
    Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations.
    Mov Disord. 2019 Feb 8. doi: 10.1002/mds.27616.
    PubMed     Text format     Abstract available

  11. YSSELSTEIN D, Shulman JM, Krainc D
    Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.
    Mov Disord. 2019 Feb 6. doi: 10.1002/mds.27631.
    PubMed     Text format     Abstract available

  12. DAFSARI HS, Martinez-Martin P, Rizos A, Trost M, et al
    EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Mov Disord. 2019 Feb 4. doi: 10.1002/mds.27626.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  13. BADEN P, Yu C, Deleidi M
    Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems.
    Neurobiol Dis. 2019 Jan 31. pii: S0969-9961(19)30032.
    PubMed     Text format     Abstract available


    Neurochem Res

  14. ZHENG X, Huang Z, Zhu Y, Liu B, et al
    Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson's Disease.
    Neurochem Res. 2019 Feb 4. pii: 10.1007/s11064-019-02739.
    PubMed     Text format     Abstract available


    Neurosci Lett

  15. GUNAYDIN C, Avci B, Bozkurt A, Onger ME, et al
    Effects of Agomelatine in Rotenone-induced Parkinson's Disease in Rats.
    Neurosci Lett. 2019 Feb 1. pii: S0304-3940(19)30075.
    PubMed     Text format     Abstract available


    Neuroscience

  16. GENG X, Wang X, He F, Zhang X, et al
    Spike and Local Field Synchronization between the Pedunculopontine Nucleus and Primary Motor Cortex in a Rat Model of Parkinson's Disease.
    Neuroscience. 2019 Jan 30. pii: S0306-4522(19)30071.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: